Trial Profile
The investigation of the effectiveness by dapagliflozin on severity of sleep disorder breathing (SDB) among the Japanese patients with type 2 diabetes mellitus
Status:
Active, no longer recruiting
Phase of Trial:
Phase II
Latest Information Update: 20 Aug 2018
Price :
$35
*
At a glance
- Drugs Dapagliflozin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 20 Oct 2015 New trial record